Tag Archives: bioresearch

March Chapter Meeting At Novartis

East Bay AWIS  is pleased to present Thursday, March 28, 2013

Roopa Ramamoorthi, PhD, PMP

Associate Director, Partnering & Scientific Affairs,  BIOVentures for Global Health

WIPO Re:Search – Sharing Innovation in theFight Against Neglected Diseases

Neglected tropical diseases, tuberculosis and malaria affect more than 1.4 billion people.  This health statistic in turn affects mortality and the ability to earn a livelihood and function effectively in school. Often affected people live in abject poverty and sometimes in conflict zones. And some so called tropical diseases are now being seen here in the United States.

WIPO Re:Search is an initiative launched over a year ago to share innovation in the fight against neglected diseases. It consists of a consortium led by the World Intellectual Property Organization (WIPO) in partnership with BIO Ventures for Global Health (BVGH), several leading pharmaceutical companies, academic institutions and research organizations world-wide to share innovation in the fight against neglected diseases.   http://www.wipo.int/research/en/

BIOVentures for Global Health (BVGH) is focused on the 19 neglected tropical diseases on WHO’s list as well as malaria and tuberculosis. As the Partnership hub administrator, BVGH works with members to identify collaboration opportunities of mutual interest and facilitates communication between members to explore and establish collaborations. http://www.bvgh.org/Biopharmaceutical-Solutions/WIPO-ReSearch/Partnership-Hub.aspx.

Dr. Ramamoorthi will speak about the initiative and share examples of collaboration agreements developed between members since the launch of the initiative.


Dr. Ramamoorthi joined BIO Ventures for Global Health (BVGH) in November 2011 as Manager, Scientific Affairs, with an extensive background in drug development, bacteriology, biotechnology, and engineering. Prior to joining BVGH, Dr. Ramamoorthi was a senior research analyst with the consulting firm Strategic Perspectives. Before that, Dr. Ramamoorthi worked with Bayer Corporation for more than five years, during which she served as a scientist and senior scientist, developing purification processes for antibodies and other complex proteins and bringing in platform technologies.

Dr. Ramamoorthi received her Ph.D. in biochemical engineering from the California Institute of Technology and conducted postdoctoral research at the University of Washington and at MIT. She is a registered patent agent and holds a Project Management Professional (PMP) certification. A native of India, where she received her B.S. in chemical engineering from the Indian Institute of Technology in Mumbai, Dr. Ramamoorthi brings a developing world perspective to her professional endeavors.

Thursday March 28, 2013

Light Dinner and Networking at 6:30 pm

Presentation at 7:00 pm

Fee: $5 for members, $10 for non-members – Register at



Location: Novartis, 5400 Hollis St, Building X-310 Emeryville, CA

Parking is in front of the Building



September Chapter Meeting

September 27, 2012 at Novartis

Therapeutic Flow for Lab Rats

Poh Teng, Ph.D.
Yoga Alliance registered Yoga Instructor
Postdoctoral Researcher, University of California, Berkeley
Four areas of the body are commonly stressed and subsequently injured due to repetitive work at the research bench and in the office: wrists, shoulders, upper back, and lower back. Learn how to prevent injuries and heal the body with simple stretches and remedies that can easily be done at the desk, in the lab, or at home. This will be an interactive class and it is recommended that you dress comfortably.
Poh studies modularity and the design of bacterial micro compartments in David Savage’s laboratory at UC Berkeley and has been practicing yoga since 2004. For more information, visit http://www.PohmYoga.com.

Best Practices for Networking

 Connie Hampton
Hampton & Associates, Scientific & Executive Search Consulting
Connie Hampton will present best practices for networking.
Hampton and Associates specializes in scientific and executive search and recruiting of professionals (MD, PhD, MBA as well as others) in biotechnology and life sciences. Connie has been in the business of finding lower-cost, higher-quality scientific and executive searches since 1997. Learn more at http://www.hampton-research.com.

Thursday, September 27, 2012

6:30-7:00 pm – Light supper and Networking

7:00-7:30 pm – Connie Hampton – Best Practices for Networking

7:30-8:30 pm – Poh Teng, PhD – Therapeutic Flow for Lab Rats

Register at this link:   http://ebawis20120927.eventbrite.com/

FEE: $5 for members, $10 for non-members.

Registering with Eventbrite  will say free, however,  fee will be collected at the door.

LOCATION: Novartis , 5400 Hollis St, Building X-310 Emeryville, CA

Parking is in front of the building

May Chapter Meeting at Novartis

Understanding and Controlling RNA-protein Complexes Involved in Myotonic Dystrophy Type 1

Professor Anne Baranger, PhD
Director of Undergraduate Chemistry,
Faculty Assistant for Teaching and Learning, &
Adjunct Professor of Chemistry

Thursday, May 24, 2012, 6:30-8:30 pm

Myotonic dystrophy is the most prevalent form of muscular dystrophy and its two forms (DM1 and DM2) affect approximately 1 in 8000 people. These diseases cannot be cured, and there are no treatment options that delay disease progression. Both diseases are caused by large expansions of repeated sequences of DNA, which is transcribed into long repeated sequences of RNA. These RNAs are toxic, as a number of cellular proteins associate with them and as a result, these proteins are not available to perform their normal functions. Chief among these proteins is muscleblind-like protein (MBNL).  In healthy cells, MBNL controls the correct expression of proteins that are important for a number of processes including relaxing muscles after contraction and insulin regulation. We have investigated the binding specificity, thermodynamics, and kinetics of the MBNL1 protein for toxic repeat RNA sequences and normal RNA target sites. We have also identified small molecules that will associate with the toxic repeat RNA and release MBNL.                                                                                

Anne Baranger received a B.S. in Chemistry from the Massachusetts Institute of Technology, a Ph.D. in Chemistry from the University of California, Berkeley, and was a postdoctoral fellow at Yale University. She joined the Wesleyan University chemistry faculty in 1996, the University of Illinois chemistry faculty in 2006, and the University of California, Berkeley chemistry faculty in 2011. At the University of Illinois, she was Associate Head of the Department, Director of Graduate Studies, and was a Chancellor’s Fellow in the I-STEM Education Initiative. At UC Berkeley, she is Director of Undergraduate Chemistry and a Faculty Assistant for Teaching and Learning.

Thursday, May 24, 2012, 6:30-8:30 pm

Light supper* and networking 6:30pm – 7:00pm

NOTE: Registering w/ Eventbrite will say FREE, however fee will be collected at the door

$5 / members, $10 / non-members

Register at:  http://ebawismaychapter2012.eventbrite.com

Location: Novartis  5400 Hollis St, Building X-310 Emeryville, CA

Park in front of building – Directions here

Non Scientists and Men Welcome